Clinical Advancements in the Targeted Therapies against Liver Fibrosis

Hepatic fibrosis, characterized by excessive accumulation of extracellular matrix (ECM) proteins leading to liver dysfunction, is a growing cause of mortality worldwide. Hepatocellular damage owing to liver injury leads to the release of profibrotic factors from infiltrating inflammatory cells that...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Ruchi, Nagórniewicz, Beata, Prakash, Jai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143744/
https://www.ncbi.nlm.nih.gov/pubmed/27999454
http://dx.doi.org/10.1155/2016/7629724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143744/
https://www.ncbi.nlm.nih.gov/pubmed/27999454
http://dx.doi.org/10.1155/2016/7629724

Ejemplares similares